Sarepta Therapeutics SRPT
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$5.65M (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 41.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 25.61% to 18.27% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Pictet Asset Management Limited | Mutual Fund | 2026/Q3 | +674,250 | 0.6% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +557,069 | 4.6% |
| FMR | Mutual Fund | 2026/Q3 | +436,859 | 0.6% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +394,816 | 1.0% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +320,053 | 8.1% |
| Public Sector Pension Investment Board | Government Pension Fund | 2026/Q3 | +301,752 | 0.6% |
| PanAgora Asset Management, Inc. | Mutual Fund | 2026/Q3 | +248,351 | 0.7% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +190,750 | 0.9% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +415,295 | 0.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +4,239,681 | 18.0% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +2,302,776 | 8.4% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +1,736,778 | 7.9% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +1,480,954 | 2.1% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +782,962 | 2.6% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +609,796 | 0.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 3 Sep 2026 | Louise Rodino-Klapac | President of Research & Development and Technical Operations | Sale to Issuer | -21,423 | $22.22 | 203,900 |
| 3 Sep 2026 | Ian Estepan | President | Sale to Issuer | -24,799 | $22.22 | 177,184 |
| 3 Sep 2026 | Cristin Rothfuss | Sale to Issuer | -22,025 | $22.22 | 115,519 | |
| 3 Sep 2026 | Ryan Wong | Chief Financial Officer | Sale to Issuer | -13,272 | $22.22 | 121,792 |
| 27 Jul 2026 | Michael Severino | Chief Executive Officer | Other Acquisition | +756,104 | – | 756,104 |
| 27 Jul 2026 | Michael Severino | Chief Executive Officer | Other Derivative Acquisition | +2,224,342 | $17.74 | 2,224,342 |
| 3 Jun 2026 | M. Behrens Wilsey | Independent Chairwoman | Other Acquisition | +16,875 | – | 16,875 |
| 3 Jun 2026 | Hans Wigzell | Chairman of Corporate Strategy Board & Independent Non-Employee Director | Other Acquisition | +16,875 | – | 16,875 |
| 3 Jun 2026 | Richard Barry | Independent Director | Other Acquisition | +16,875 | – | 16,875 |
| 3 Jun 2026 | Michael Chambers | Independent Director | Other Acquisition | +16,875 | – | 16,875 |
| 3 Jun 2026 | Deirdre Connelly | Independent Director | Other Acquisition | +16,875 | – | 18,770 |
| 3 Jun 2026 | Stephen Mayo | Independent Director | Other Acquisition | +16,875 | – | 16,875 |
| 3 Jun 2026 | Claude Nicaise | Independent Director | Other Acquisition | +16,875 | – | 16,875 |
| 3 Jun 2026 | Kathryn Boor | Independent Director | Other Acquisition | +16,875 | – | 16,875 |
| 11 Mar 2026 | Stephen Mayo | Independent Director | Open Market Disposition | -7,239 | $17.02 | 1,765 |
| 10 Mar 2026 | Louise Rodino-Klapac | President of Research & Development and Technical Operations | Sale to Issuer | -948 | $17.03 | 225,323 |
| 10 Mar 2026 | Ian Estepan | President | Sale to Issuer | -1,097 | $17.03 | 201,983 |
| 10 Mar 2026 | Cristin Rothfuss | Sale to Issuer | -974 | $17.03 | 137,544 | |
| 10 Mar 2026 | Ryan Wong | Chief Financial Officer | Sale to Issuer | -256 | $17.03 | 135,064 |
| 8 Mar 2026 | Louise Rodino-Klapac | President of Research & Development and Technical Operations | Sale to Issuer | -1,399 | $16.95 | 226,271 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 19,297,522 | 18.3% | 7.8 |
| 15 Oct 2026 | 22,330,342 | 21.1% | 7.5 |
| 30 Sep 2026 | 22,784,187 | 21.6% | 8.6 |
| 15 Sep 2026 | 25,434,681 | 24.1% | 8.0 |
| 31 Aug 2026 | 24,621,090 | 23.3% | 8.5 |
| 14 Aug 2026 | 27,049,885 | 25.6% | 9.1 |
No comments yet — be the first to weigh in on SRPT.
Sign in to join the discussion.